Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID
· Real-Time Price · USD
1.29
-0.04 (-3.01%)
At close: Sep 04, 2025, 3:59 PM
1.30
0.78%
Pre-market: Sep 05, 2025, 08:59 AM EDT
-3.01% (1D)
| Bid | 1.25 |
| Market Cap | 91.73M |
| Revenue (ttm) | 6.65M |
| Net Income (ttm) | -38.18M |
| EPS (ttm) | -0.54 |
| PE Ratio (ttm) | -2.39 |
| Forward PE | -2.33 |
| Analyst | Buy |
| Ask | 1.35 |
| Volume | 1,193,618 |
| Avg. Volume (20D) | 1,970,814 |
| Open | 1.28 |
| Previous Close | 1.33 |
| Day's Range | 1.27 - 1.34 |
| 52-Week Range | 0.24 - 1.47 |
| Beta | 0.21 |
About OVID
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OVID
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OVID stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Ovid Therapeutics Inc. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+56.86%
Ovid Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
3 months ago
+3.11%
Ovid Therapeutics shares are trading higher after the company reported better-than-expected Q1 sales results.
